American Bio Medica Corporation (ABMC)

OTCMKTS: ABMC · Delayed Price · USD
0.0003
0.00 (0.00%)
Mar 14, 2024, 10:37 AM EDT - Market closed

Company Description

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids.

Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs.

The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat.

In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases.

Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies.

The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets.

It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992.

American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

American Bio Medica Corporation
Country NY
Founded 1986
IPO Date Dec 24, 1997
Industry Diagnostics & Research
Sector Healthcare
Employees 16
CEO Ms. Jean Neff

Contact Details

Address:
122 Smith Road
Kinderhook, New York 12106
United States
Phone 5187588158
Website abmc.com

Stock Details

Ticker Symbol ABMC
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000896747
CUSIP Number 024600108
ISIN Number US0246001087
Employer ID 14-1702188
SIC Code 2834

Key Executives

Name Position
Jean Neff Corporate Secretary and Independent Director
J. Duncan Urquhart Controller

Latest SEC Filings

Date Type Title
Jun 12, 2023 10-Q Quarterly Report
May 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Mar 21, 2023 10-K Annual Report
Mar 1, 2023 8-K Current Report
Feb 17, 2023 8-K Current Report
Jan 11, 2023 DEF 14A Other definitive proxy statements
Jan 5, 2023 PRER14A Filing
Dec 22, 2022 PRE 14A Other preliminary proxy statements
Dec 21, 2022 8-K Current Report
Nov 16, 2022 10-Q Quarterly Report